2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Menomune-A & C & Y & W-135 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-6J12441
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Menomune A C Y W 135 Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Menomune-A & C & Y & W-135 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6J12441
Report
September 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Menomune-A & C & Y & W-135 - Market Size

The global market for Menomune-A & C & Y & W-135 was estimated to be worth US$ 1354 million in 2023 and is forecast to a readjusted size of US$ 1802.2 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

Menomune-A & C & Y & W-135 - Market

Menomune-A & C & Y & W-135 - Market

Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Menomune-A & C & Y & W-135, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Menomune-A & C & Y & W-135 by region & country, by Type, and by Application.
The Menomune-A & C & Y & W-135 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menomune-A & C & Y & W-135.
Market Segmentation

Scope of Menomune-A & C & Y & W-135 - Market Report

Report Metric Details
Report Name Menomune-A & C & Y & W-135 - Market
Forecasted market size in 2030 US$ 1802.2 million
CAGR 4.2%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Public
  • Private
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi Pasteur, GSK, Hualan Bio, Beijing Luzhu Biopharmaceutical, Walvax, Kanghua Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Menomune-A & C & Y & W-135 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Menomune-A & C & Y & W-135 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Menomune-A & C & Y & W-135 in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Menomune-A & C & Y & W-135 - Market size in 2030?

Ans: The Menomune-A & C & Y & W-135 - Market size in 2030 will be US$ 1802.2 million.

Who are the main players in the Menomune-A & C & Y & W-135 - Market report?

Ans: The main players in the Menomune-A & C & Y & W-135 - Market are Sanofi Pasteur, GSK, Hualan Bio, Beijing Luzhu Biopharmaceutical, Walvax, Kanghua Bio

What are the Application segmentation covered in the Menomune-A & C & Y & W-135 - Market report?

Ans: The Applications covered in the Menomune-A & C & Y & W-135 - Market report are Public, Private

What are the Type segmentation covered in the Menomune-A & C & Y & W-135 - Market report?

Ans: The Types covered in the Menomune-A & C & Y & W-135 - Market report are Oligosaccharide, Polysaccharide

Recommended Reports

Meningococcal Vaccines

Vaccine Packaging

Pharma Excipients & Drugs

1 Market Overview
1.1 Menomune-A & C & Y & W-135 Product Introduction
1.2 Global Menomune-A & C & Y & W-135 Market Size Forecast
1.2.1 Global Menomune-A & C & Y & W-135 Sales Value (2019-2030)
1.2.2 Global Menomune-A & C & Y & W-135 Sales Volume (2019-2030)
1.2.3 Global Menomune-A & C & Y & W-135 Sales Price (2019-2030)
1.3 Menomune-A & C & Y & W-135 Market Trends & Drivers
1.3.1 Menomune-A & C & Y & W-135 Industry Trends
1.3.2 Menomune-A & C & Y & W-135 Market Drivers & Opportunity
1.3.3 Menomune-A & C & Y & W-135 Market Challenges
1.3.4 Menomune-A & C & Y & W-135 Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Menomune-A & C & Y & W-135 Players Revenue Ranking (2023)
2.2 Global Menomune-A & C & Y & W-135 Revenue by Company (2019-2024)
2.3 Global Menomune-A & C & Y & W-135 Players Sales Volume Ranking (2023)
2.4 Global Menomune-A & C & Y & W-135 Sales Volume by Company Players (2019-2024)
2.5 Global Menomune-A & C & Y & W-135 Average Price by Company (2019-2024)
2.6 Key Manufacturers Menomune-A & C & Y & W-135 Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Menomune-A & C & Y & W-135 Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Menomune-A & C & Y & W-135
2.9 Menomune-A & C & Y & W-135 Market Competitive Analysis
2.9.1 Menomune-A & C & Y & W-135 Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Menomune-A & C & Y & W-135 Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menomune-A & C & Y & W-135 as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oligosaccharide
3.1.2 Polysaccharide
3.2 Global Menomune-A & C & Y & W-135 Sales Value by Type
3.2.1 Global Menomune-A & C & Y & W-135 Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Menomune-A & C & Y & W-135 Sales Value, by Type (2019-2030)
3.2.3 Global Menomune-A & C & Y & W-135 Sales Value, by Type (%) (2019-2030)
3.3 Global Menomune-A & C & Y & W-135 Sales Volume by Type
3.3.1 Global Menomune-A & C & Y & W-135 Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Menomune-A & C & Y & W-135 Sales Volume, by Type (2019-2030)
3.3.3 Global Menomune-A & C & Y & W-135 Sales Volume, by Type (%) (2019-2030)
3.4 Global Menomune-A & C & Y & W-135 Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Public
4.1.2 Private
4.2 Global Menomune-A & C & Y & W-135 Sales Value by Application
4.2.1 Global Menomune-A & C & Y & W-135 Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Menomune-A & C & Y & W-135 Sales Value, by Application (2019-2030)
4.2.3 Global Menomune-A & C & Y & W-135 Sales Value, by Application (%) (2019-2030)
4.3 Global Menomune-A & C & Y & W-135 Sales Volume by Application
4.3.1 Global Menomune-A & C & Y & W-135 Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Menomune-A & C & Y & W-135 Sales Volume, by Application (2019-2030)
4.3.3 Global Menomune-A & C & Y & W-135 Sales Volume, by Application (%) (2019-2030)
4.4 Global Menomune-A & C & Y & W-135 Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Menomune-A & C & Y & W-135 Sales Value by Region
5.1.1 Global Menomune-A & C & Y & W-135 Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Menomune-A & C & Y & W-135 Sales Value by Region (2019-2024)
5.1.3 Global Menomune-A & C & Y & W-135 Sales Value by Region (2025-2030)
5.1.4 Global Menomune-A & C & Y & W-135 Sales Value by Region (%), (2019-2030)
5.2 Global Menomune-A & C & Y & W-135 Sales Volume by Region
5.2.1 Global Menomune-A & C & Y & W-135 Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Menomune-A & C & Y & W-135 Sales Volume by Region (2019-2024)
5.2.3 Global Menomune-A & C & Y & W-135 Sales Volume by Region (2025-2030)
5.2.4 Global Menomune-A & C & Y & W-135 Sales Volume by Region (%), (2019-2030)
5.3 Global Menomune-A & C & Y & W-135 Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Menomune-A & C & Y & W-135 Sales Value, 2019-2030
5.4.2 North America Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Menomune-A & C & Y & W-135 Sales Value, 2019-2030
5.5.2 Europe Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Menomune-A & C & Y & W-135 Sales Value, 2019-2030
5.6.2 Asia Pacific Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Menomune-A & C & Y & W-135 Sales Value, 2019-2030
5.7.2 South America Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Menomune-A & C & Y & W-135 Sales Value, 2019-2030
5.8.2 Middle East & Africa Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value
6.2.1 Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.2.2 Key Countries/Regions Menomune-A & C & Y & W-135 Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.3.2 United States Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.4.2 Europe Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.5.2 China Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.5.3 China Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.6.2 Japan Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.7.2 South Korea Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.8.2 Southeast Asia Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Menomune-A & C & Y & W-135 Sales Value, 2019-2030
6.9.2 India Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
6.9.3 India Menomune-A & C & Y & W-135 Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Information
7.1.2 Sanofi Pasteur Introduction and Business Overview
7.1.3 Sanofi Pasteur Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Menomune-A & C & Y & W-135 Product Offerings
7.1.5 Sanofi Pasteur Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Introduction and Business Overview
7.2.3 GSK Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GSK Menomune-A & C & Y & W-135 Product Offerings
7.2.5 GSK Recent Development
7.3 Hualan Bio
7.3.1 Hualan Bio Company Information
7.3.2 Hualan Bio Introduction and Business Overview
7.3.3 Hualan Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Hualan Bio Menomune-A & C & Y & W-135 Product Offerings
7.3.5 Hualan Bio Recent Development
7.4 Beijing Luzhu Biopharmaceutical
7.4.1 Beijing Luzhu Biopharmaceutical Company Information
7.4.2 Beijing Luzhu Biopharmaceutical Introduction and Business Overview
7.4.3 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Product Offerings
7.4.5 Beijing Luzhu Biopharmaceutical Recent Development
7.5 Walvax
7.5.1 Walvax Company Information
7.5.2 Walvax Introduction and Business Overview
7.5.3 Walvax Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Walvax Menomune-A & C & Y & W-135 Product Offerings
7.5.5 Walvax Recent Development
7.6 Kanghua Bio
7.6.1 Kanghua Bio Company Information
7.6.2 Kanghua Bio Introduction and Business Overview
7.6.3 Kanghua Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kanghua Bio Menomune-A & C & Y & W-135 Product Offerings
7.6.5 Kanghua Bio Recent Development
8 Industry Chain Analysis
8.1 Menomune-A & C & Y & W-135 Industrial Chain
8.2 Menomune-A & C & Y & W-135 Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Menomune-A & C & Y & W-135 Sales Model
8.5.2 Sales Channel
8.5.3 Menomune-A & C & Y & W-135 Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Menomune-A & C & Y & W-135 Market Trends
    Table 2. Menomune-A & C & Y & W-135 Market Drivers & Opportunity
    Table 3. Menomune-A & C & Y & W-135 Market Challenges
    Table 4. Menomune-A & C & Y & W-135 Market Restraints
    Table 5. Global Menomune-A & C & Y & W-135 Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Menomune-A & C & Y & W-135 Revenue Market Share by Company (2019-2024)
    Table 7. Global Menomune-A & C & Y & W-135 Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Menomune-A & C & Y & W-135 Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Menomune-A & C & Y & W-135 Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Menomune-A & C & Y & W-135 Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Menomune-A & C & Y & W-135 Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Menomune-A & C & Y & W-135
    Table 13. Global Menomune-A & C & Y & W-135 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menomune-A & C & Y & W-135 as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Menomune-A & C & Y & W-135 Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Menomune-A & C & Y & W-135 Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Menomune-A & C & Y & W-135 Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Menomune-A & C & Y & W-135 Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Menomune-A & C & Y & W-135 Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Menomune-A & C & Y & W-135 Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Menomune-A & C & Y & W-135 Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Menomune-A & C & Y & W-135 Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Menomune-A & C & Y & W-135 Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Menomune-A & C & Y & W-135 Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Menomune-A & C & Y & W-135 Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Menomune-A & C & Y & W-135 Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Menomune-A & C & Y & W-135 Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Menomune-A & C & Y & W-135 Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Menomune-A & C & Y & W-135 Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Menomune-A & C & Y & W-135 Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Menomune-A & C & Y & W-135 Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Menomune-A & C & Y & W-135 Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Menomune-A & C & Y & W-135 Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Menomune-A & C & Y & W-135 Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Menomune-A & C & Y & W-135 Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Menomune-A & C & Y & W-135 Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Menomune-A & C & Y & W-135 Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Menomune-A & C & Y & W-135 Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Menomune-A & C & Y & W-135 Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Menomune-A & C & Y & W-135 Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Menomune-A & C & Y & W-135 Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Menomune-A & C & Y & W-135 Sales Value by Region (2019-2024) & (%)
    Table 44. Global Menomune-A & C & Y & W-135 Sales Value by Region (2025-2030) & (%)
    Table 45. Global Menomune-A & C & Y & W-135 Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Menomune-A & C & Y & W-135 Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Menomune-A & C & Y & W-135 Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Menomune-A & C & Y & W-135 Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Menomune-A & C & Y & W-135 Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Menomune-A & C & Y & W-135 Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Menomune-A & C & Y & W-135 Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Volume, (2025-2030) & (K Units)
    Table 57. Sanofi Pasteur Company Information
    Table 58. Sanofi Pasteur Introduction and Business Overview
    Table 59. Sanofi Pasteur Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Sanofi Pasteur Menomune-A & C & Y & W-135 Product Offerings
    Table 61. Sanofi Pasteur Recent Development
    Table 62. GSK Company Information
    Table 63. GSK Introduction and Business Overview
    Table 64. GSK Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. GSK Menomune-A & C & Y & W-135 Product Offerings
    Table 66. GSK Recent Development
    Table 67. Hualan Bio Company Information
    Table 68. Hualan Bio Introduction and Business Overview
    Table 69. Hualan Bio Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Hualan Bio Menomune-A & C & Y & W-135 Product Offerings
    Table 71. Hualan Bio Recent Development
    Table 72. Beijing Luzhu Biopharmaceutical Company Information
    Table 73. Beijing Luzhu Biopharmaceutical Introduction and Business Overview
    Table 74. Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Product Offerings
    Table 76. Beijing Luzhu Biopharmaceutical Recent Development
    Table 77. Walvax Company Information
    Table 78. Walvax Introduction and Business Overview
    Table 79. Walvax Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Walvax Menomune-A & C & Y & W-135 Product Offerings
    Table 81. Walvax Recent Development
    Table 82. Kanghua Bio Company Information
    Table 83. Kanghua Bio Introduction and Business Overview
    Table 84. Kanghua Bio Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Kanghua Bio Menomune-A & C & Y & W-135 Product Offerings
    Table 86. Kanghua Bio Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Menomune-A & C & Y & W-135 Downstream Customers
    Table 90. Menomune-A & C & Y & W-135 Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Menomune-A & C & Y & W-135 Product Picture
    Figure 2. Global Menomune-A & C & Y & W-135 Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Menomune-A & C & Y & W-135 Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Menomune-A & C & Y & W-135 Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Menomune-A & C & Y & W-135 Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Menomune-A & C & Y & W-135 Report Years Considered
    Figure 7. Global Menomune-A & C & Y & W-135 Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Menomune-A & C & Y & W-135 Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Menomune-A & C & Y & W-135 Revenue in 2023
    Figure 10. Menomune-A & C & Y & W-135 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oligosaccharide Picture
    Figure 12. Polysaccharide Picture
    Figure 13. Global Menomune-A & C & Y & W-135 Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Menomune-A & C & Y & W-135 Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Menomune-A & C & Y & W-135 Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Menomune-A & C & Y & W-135 Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Menomune-A & C & Y & W-135 Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Public
    Figure 19. Product Picture of Private
    Figure 20. Global Menomune-A & C & Y & W-135 Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Menomune-A & C & Y & W-135 Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Menomune-A & C & Y & W-135 Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Menomune-A & C & Y & W-135 Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Menomune-A & C & Y & W-135 Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Menomune-A & C & Y & W-135 Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Menomune-A & C & Y & W-135 Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Menomune-A & C & Y & W-135 Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Menomune-A & C & Y & W-135 Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Menomune-A & C & Y & W-135 Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Menomune-A & C & Y & W-135 Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Menomune-A & C & Y & W-135 Sales Volume (%), (2019-2030)
    Figure 37. United States Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Menomune-A & C & Y & W-135 Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Menomune-A & C & Y & W-135 Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Menomune-A & C & Y & W-135 Sales Value by Application (%), 2023 VS 2030
    Figure 58. Menomune-A & C & Y & W-135 Industrial Chain
    Figure 59. Menomune-A & C & Y & W-135 Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS